Xiaoling Li
Impact in
- Geriatrics and Gerontology top 0.05%
- Sirtuins and Resveratrol in Medicine
- Cancer Research top 0.2%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
Papers in
-
- Cancer-related molecular mechanisms research 49
- MicroRNA in disease regulation 28
-
- Sirtuins and Resveratrol in Medicine 38
- Co-authors
- Guiyuan Li (106 shared papers)Zhaoyang Zeng (66 shared papers)Wei Xiong (52 shared papers)Thaddeus T. Schug (8 shared papers)Bo Xiang (46 shared papers)Yong Li (25 shared papers)Can Jie Guo (27 shared papers)Stephen John Gould (6 shared papers)
- Journals
- Journal of Cancer (10 papers)Oncotarget (10 papers)Molecular Cancer (9 papers)PLoS ONE (8 papers)Journal of Experimental & Clinical Cancer Research (8 papers)
- Partner nations
- ChinaUnited StatesSaudi Arabia
In The Last Decade
Xiaoling Li
423 papers receiving 25.1k citations
Xiaoling Li's Hit Papers
Peers
Comparison fields: 5 of 190
- Geriatrics and Gerontology 2.3k
- Cancer Research 6.0k
- Molecular Biology 12.7k
- Oncology 3.9k
- Immunology 2.6k
Countries citing papers authored by Xiaoling Li
This map shows the geographic impact of Xiaoling Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoling Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoling Li more than expected).
Fields of papers citing papers by Xiaoling Li
This network shows the impact of papers produced by Xiaoling Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoling Li. The network helps show where Xiaoling Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaoling Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 440 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Role of the tumor microenvironment in PD-L1/PD-1-mediated tumor immune escape Hit paper breakdown → | 2019 | 1159 |
| 2 | Hepatocyte-Specific Deletion of SIRT1 Alters Fatty Acid Metabolism and Results in Hepatic Steatosis and Inflammation Hit paper breakdown → | 2009 | 961 |
| 3 | Circular RNAs function as ceRNAs to regulate and control human cancer progression Hit paper breakdown → | 2018 | 787 |
| 4 | 2007 | 547 | |
| 5 | Function of the c-Met receptor tyrosine kinase in carcinogenesis and associated therapeutic opportunities Hit paper breakdown → | 2018 | 472 |
| 6 | Emerging role of tumor-related functional peptides encoded by lncRNA and circRNA Hit paper breakdown → | 2020 | 434 |
| 7 | Pyroptosis: a new paradigm of cell death for fighting against cancer Hit paper breakdown → | 2021 | 374 |
| 8 | Mechanisms of vasculogenic mimicry in hypoxic tumor microenvironments Hit paper breakdown → | 2021 | 347 |
| 9 | 2018 | 335 | |
| 10 | 2012 | 325 | |
| 11 | 2020 | 306 | |
| 12 | 2010 | 293 | |
| 13 | 2017 | 290 | |
| 14 | 2012 | 288 | |
| 15 | Adebrelimab or placebo plus carboplatin and etoposide as first-line treatment for extensive-stage small-cell lung cancer (CAPSTONE-1): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial Hit paper breakdown → | 2022 | 285 |
| 16 | 2000 | 270 | |
| 17 | Chronic Stress Promotes Cancer Development Hit paper breakdown → | 2020 | 261 |
| 18 | 2011 | 248 | |
| 19 | 2020 | 244 | |
| 20 | 1997 | 236 |
About Xiaoling Li
Xiaoling Li is a scholar working on Cancer Research, Geriatrics and Gerontology, Molecular Biology, Oncology and Immunology, having authored 440 papers that have together received 25.5k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (49 papers), RNA modifications and cancer (46 papers), Sirtuins and Resveratrol in Medicine (38 papers), MicroRNA in disease regulation (28 papers), Circular RNAs in diseases (20 papers), RNA Research and Splicing (19 papers), Selenium in Biological Systems (19 papers) and Autophagy in Disease and Therapy (18 papers). The work is most often cited by research in Geriatrics and Gerontology (2.3k citations), Cancer Research (6.0k citations), Molecular Biology (12.7k citations), Oncology (3.9k citations) and Immunology (2.6k citations). Xiaoling Li has collaborated with scholars based in China, United States and Saudi Arabia. Frequent co-authors include Guiyuan Li, Zhaoyang Zeng, Wei Xiong, Thaddeus T. Schug, Bo Xiang, Yong Li, Can Jie Guo, Stephen John Gould, Tianfeng Chen and Qing Xu. Their work appears in journals such as Journal of Cancer, Oncotarget, Molecular Cancer, PLoS ONE and Journal of Experimental & Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.